Report Overview

The China HRT market size stood at around USD XX billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of 4.6% during the forecast period.

Most Chinese women had knowledge of menopause and thought menopausal symptoms should not be treated. The awareness of HRT was poor and influenced by menopausal, working, and marital status. Chinese healthcare providers have to assume responsibility for educating women about menopause and HRT use. HRT awareness among Chinese women was 3.5% and was related to menopausal, working, and marital status; (2.1%) women had used or were using HRT, of which 57.3% used HRT with a doctor's prescription and 29.3% experienced side-effects from the use of HRT.



Market Drivers

The major factors that contribute toward the growth of the hormone replacement therapy market include a rise in the prevalence of menopausal disorder and an increase in awareness about post-menopausal issues among women. In addition, new launches of hormone replacement therapy are expected to notably contribute toward the hormone replacement therapy market growth. However, adverse effects of hormone replacement therapy and the high cost of treatment are anticipated to hamper the market growth during the forecast period. On the contrary, the introduction of bioidentical hormone replacement therapy and leveraging telemedicine for hormone replacement therapy are expected to provide remunerative opportunities for the expansion of the hormone replacement therapy market.